Pancreatic Cancer Research

ResearcherUniversity of MichiganActive in the last 2 years

Erqi Liu Pollom

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-2908-6293; OpenAlex author ID A5073413027. Sources: OpenAlex.

Their work

Papers
12 (first author 3, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
28
Papers, trials and grants by year

2011: 1 paper · 2012: none · 2013: none · 2014: 1 paper · 2015: 1 paper · 2016: 1 paper · 2017: 2 papers · 2018: 1 paper · 2019: 1 paper · 2020: 2 papers · 2021: none · 2022: none · 2023: 1 paper · 2024: none · 2025: none · 2026: 1 paper

Papers 12

  1. Biochemical, Radiographic, or Pathologic Response to Neoadjuvant Chemotherapy in Resected Pancreatic Cancer: Which Is Best? Co-author DOI 10.1097/sla.0000000000006609↗
  2. Validation of a Resectability Scoring System for Prediction of Pancreatic Adenocarcinoma Surgical Outcomes. Co-author DOI 10.1245/s10434-023-13120-3↗
  3. The Utility of Stereotactic Ablative Radiation Therapy for Palliation of Metastatic Pancreatic Adenocarcinoma. Co-author DOI 10.1016/j.prro.2020.02.010↗
  4. Intensified systemic therapy and stereotactic ablative radiotherapy dose for patients with unresectable pancreatic adenocarcinoma. Co-author DOI 10.1016/j.radonc.2020.07.053↗
  5. Predicting Pancreatic Cancer Resectability and Outcomes Based on an Objective Quantitative Scoring System. Co-author DOI 10.1097/mpa.0000000000001314↗
  6. Albumin and Neutrophil-Lymphocyte Ratio (NLR) Predict Survival in Patients With Pancreatic Adenocarcinoma Treated With SBRT. First author DOI 10.1097/coc.0000000000000263↗
  7. Reirradiation with stereotactic body radiation therapy after prior conventional fractionation radiation for locally recurrent pancreatic adenocarcinoma. Co-author DOI 10.1016/j.adro.2017.01.003↗
  8. Assessing local progression after stereotactic body radiation therapy for unresectable pancreatic adenocarcinoma: CT versus PET. First author DOI 10.1016/j.prro.2016.09.002↗
  9. Quantitative Analysis of (18)F-Fluorodeoxyglucose Positron Emission Tomography Identifies Novel Prognostic Imaging Biomarkers in Locally Advanced Pancreatic Ca… Co-author DOI 10.1016/j.ijrobp.2016.04.034↗
  10. Treatment Approaches to Locally Advanced Pancreatic Adenocarcinoma. Co-author DOI 10.1016/j.hoc.2015.04.005↗
  11. Single- versus multifraction stereotactic body radiation therapy for pancreatic adenocarcinoma: outcomes and toxicity. Co-author DOI 10.1016/j.ijrobp.2014.06.066↗
  12. Selective radiosensitization of p53 mutant pancreatic cancer cells by combined inhibition of Chk1 and PARP1. First author DOI 10.4161/cc.10.24.18661↗

Closest collaborators

The 25 strongest of 28 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Daniel Tandel Chang · 10 shared papers, 2014–2026 · strength 1.09
  2. Albert C. Koong · 9 shared papers, 2014–2023 · strength 0.84
  3. Diego A.S. Toesca · 6 shared papers, 2017–2023 · strength 0.66
  4. George A. Poultsides · 5 shared papers, 2014–2026 · strength 0.62
  5. Brendan Christopher Visser · 4 shared papers, 2014–2026 · strength 0.54
  6. George Albert Fisher · 4 shared papers, 2014–2026 · strength 0.54
  7. Jeffrey Allen Norton · 2 shared papers, 2014–2026 · strength 0.28
  8. R. Brooke Jeffrey · 2 shared papers, 2019–2023 · strength 0.25
  9. M. Usman Ahmad · 1 shared paper, 2026 · strength 0.24
  10. Byrne Lee · 1 shared paper, 2026 · strength 0.24
  11. Gregory M. Heestand · 1 shared paper, 2026 · strength 0.24
  12. Daniel Delitto · 1 shared paper, 2026 · strength 0.24
  13. Amanda Kirane · 1 shared paper, 2026 · strength 0.24
  14. Amanda Jeanette Koong · 2 shared papers, 2017–2020 · strength 0.22
  15. Muthuraman Alagappan · 3 shared papers, 2014–2018 · strength 0.18
  16. Mary Uan-Sian Feng · 1 shared paper, 2023 · strength 0.16
  17. Yi Cui · 2 shared papers, 2016–2017 · strength 0.13
  18. Margaret M. Kozak · 1 shared paper, 2018 · strength 0.09
  19. Andrew H. Ko · 1 shared paper, 2015 · strength 0.08
  20. Ruijiang Li · 1 shared paper, 2016 · strength 0.06
  21. James M. Ford · 1 shared paper, 2014 · strength 0.04
  22. Aya Kamaya · 1 shared paper, 2014 · strength 0.04
  23. Pamela L. Kunz · 1 shared paper, 2014 · strength 0.04
  24. Leslie A. Parsels · 1 shared paper, 2011 · strength 0.03
  25. Theodore Steven Lawrence · 1 shared paper, 2011 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.